3M CO Deferred Revenue Recognized
3M CO (MMM) reported Deferred Revenue Recognized of $210.00 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-30.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2024-04-30
- 3M CO contract with customer, liability, revenue recognized for the quarter ending 2024-03-31 was $210.00M, a 5.00% increase year-over-year.
- 3M CO contract with customer, liability, revenue recognized for the quarter ending 2023-09-30 was $110.00M, a 10.00% increase year-over-year.
- 3M CO contract with customer, liability, revenue recognized for the quarter ending 2023-06-30 was $150.00M, a 7.14% increase year-over-year.
- 3M CO contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was $200.00M, a 0.00% change year-over-year.
- 3M CO contract with customer, liability, revenue recognized for fiscal 2023 was $520.00M, a 4.00% increase from fiscal 2022.
- 3M CO contract with customer, liability, revenue recognized for fiscal 2022 was $500.00M, a 6.38% increase from fiscal 2021.
- 3M CO contract with customer, liability, revenue recognized for fiscal 2021 was $470.00M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|
| 2024-03-31 | $210.00M 10-Q · filed 2024-04-30 | ||||
| 2023-12-31 | $520.00M 10-K · filed 2024-02-07 | ||||
| 2023-09-30 | $110.00M 10-Q · filed 2023-10-24 | $460.00M 10-Q · filed 2023-10-24 | |||
| 2023-06-30 | $150.00M 10-Q · filed 2023-07-25 | $350.00M 10-Q · filed 2023-07-25 | |||
| 2023-03-31 | $200.00M 10-Q · filed 2024-04-30 | ||||
| 2022-12-31 | $500.00M 10-K · filed 2024-02-07 | ||||
| 2022-09-30 | $100.00M 10-Q · filed 2023-10-24 | $440.00M 10-Q · filed 2023-10-24 | |||
| 2022-06-30 | $140.00M 10-Q · filed 2023-07-25 | $340.00M 10-Q · filed 2023-07-25 | |||
| 2022-03-31 | $200.00M 10-Q · filed 2023-04-25 | ||||
| 2021-12-31 | $470.00M 10-K · filed 2023-02-08 | ||||
| 2021-09-30 | $90.00M 10-Q · filed 2022-10-25 | $410.00M 10-Q · filed 2022-10-25 | |||
| 2021-06-30 | $140.00M 10-Q · filed 2022-07-27 | $320.00M 10-Q · filed 2022-07-27 | |||
| 2021-03-31 | $180.00M 10-Q · filed 2022-04-26 | ||||
| 2020-12-31 | $410.00M 8-K · filed 2022-04-26 | $160.00M 10-Q · filed 2021-04-27 | |||
| 2020-09-30 | $100.00M 10-Q · filed 2021-10-26 | $370.00M 10-Q · filed 2021-10-26 | |||
| 2020-06-30 | $110.00M 10-Q · filed 2021-07-27 | $270.00M 10-Q · filed 2021-07-27 | |||
| 2020-03-31 | $160.00M 10-Q · filed 2020-04-28 | ||||
| 2019-09-30 | $80.00M 10-Q · filed 2020-10-27 | $560.00M 10-Q · filed 2020-10-27 | |||
| 2019-06-30 | $110.00M 10-Q · filed 2020-07-28 | $480.00M 10-Q · filed 2020-07-28 | |||
| 2019-03-31 | $370.00M 10-Q · filed 2020-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |